Parkinson's Disease Trial, Recruiting (NCT05658302)

Parkinson's Disease Trial, Recruiting NCT05658302 Sponsor: University of Minnesota Condition: Parkinson's Disease

Printed from Voxsanity (voxsanity.com.au) — NCT05658302 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Parkinsons Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with idiopathic Parkinson's disease (Parkinson's disease with no known external cause)
People who are already scheduled to have deep brain stimulation (DBS) surgery at the University of Minnesota as part of their regular medical care, using specific types of implanted hardware (directional leads and a particular type of pulse generator)
People who are at least 21 years old

Who may not be able to join:

People who have another significant neurological condition in addition to Parkinson's disease
People who have a history of dementia
People who experience certain complications or side effects after surgery that affect their safety or would interfere with the study results
People who are pregnant
People who have had radiation exposure within the last year that, when combined with the radiation expected during a part of the surgical procedure, would be considered unsafe (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 612-625-4947

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05658302

Sponsor: University of Minnesota

Phase: Not Applicable

Status: Recruiting

Condition: Parkinson's Disease

Trial contact: 612-625-4947

More information: https://clinicaltrials.gov/study/NCT05658302

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with idiopathic Parkinson's disease (Parkinson's disease with no known external cause)
People who are already scheduled to have deep brain stimulation (DBS) surgery at the University of Minnesota as part of their regular medical care, using specific types of implanted hardware (directional leads and a particular type of pulse generator)
People who are at least 21 years old

Who may not be able to join:

People who have another significant neurological condition in addition to Parkinson's disease
People who have a history of dementia
People who experience certain complications or side effects after surgery that affect their safety or would interfere with the study results
People who are pregnant
People who have had radiation exposure within the last year that, when combined with the radiation expected during a part of the surgical procedure, would be considered unsafe (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Minnesota

Registry

ClinicalTrials.gov

Start date

28 March 2023

Est. completion

1 March 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

reach-related modulation; N-back task trials; rigidity and bradykinesia assessments; peak frequency of the ERs + spontaneous LFPs

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov